Enter inventor name

Serge Auvin

This inventor holds 35 USPTO granted patents and 7 EPO patents, primarily in Medicinal Chemistry. Top assignees: Societe De Conseils De Recherches Et D'applications Scientifiques (s.c.r.a.s.), Ipsen Pharma S.a.s., Societe De Conseils De Recherches Et D'applications Scientifiques. Active years: 1994-2018.

USPTO Granted Patents = 35

% Patents Active = 25.7

EPO Patents = 7 (Patent Applications = 5)

Average Co-Inventor Count = 4.0

ph-index = 8

Forward Citations = 217(Granted Patents)

Location History:

St Michel, FR (1995)
Michel-Sur-Orge, FR (1996)
Saint-Michel-Sur-Orge, FR (1994 - 2003)
Mauchamps, FR (2002 - 2009)
Palaiseau, FR (2008 - 2018)

Company Filing History:

20 out of 119

Societe De Conseils De Recherches Et D'applications Scientifiques (s.c.r.a.s.)

Societe De Conseils De Recherches Et D'applications Scientifiques

Estryx Pharma Limited

patent

6. 1 out of 3

Societe De Conseils De Recherches Et D'applications (s.c.r.a.s.)

patents

7. 1 out of 834,307

Other

patents

Years Active: 1994-2018

Loading Chart...

Areas of Expertise:

Imidazolidine Derivatives

Amidine Compounds

Cancer Drug

Phenothiazine Derivatives

Calpain Inhibitors

2-Aminopyridine Derivatives

Dual Inhibitors

Heterocyclic Compounds

Pharmaceutical Compositions

Medicaments

Reactive Oxygen Species

Amino Acid Derivatives

35 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9975880 - Imidazolidine-2,4-dione dervatives (2018-05-22),

2. 9682941 - Substituted biphenyl analogues as dual inhibitors of aromatase and sulfatase (2017-06-20),

3. 9676752 - Imidazolidine-2,4-dione derivatives (2017-06-13),

4. 8710091 - Imidazolidine-2,4-dione derivatives, and use thereof as a cancer drug (2014-04-29),

5. 8642591 - Composition containing amidine derivatives or carboxamide derivatives and steroids, as a medicament (2014-02-04),

6. 8624037 - Imidazolidine-2,4-dione derivatives and use thereof as a medicament (2014-01-07),

7. 7696197 - Use of a phenothiazine derivative for preventing and/or treating hearing loss (2010-04-13),

8. 7659266 - Amidine derivatives and their applications as a medicament (2010-02-09),

9. 7576241 - Derivatives of amidines, their preparation, their use as medicaments and the pharmaceutical compositions containing them (2009-08-18),

10. 7553976 - Derivatives of 2-(iminomethyl)amino-phenyl, their preparation, their use as medicaments and the pharmaceutical compositions containing them (2009-06-30),

11. 7473779 - Derivatives of amidines, their preparation, their use as medicaments and the pharmaceutical compositions containing them (2009-01-06),

12. 7465721 - 2-hydroxytetrahydrofuran derivatives and use thereof as medicaments (2008-12-16),

13. 7459558 - Derivatives of 2-(iminomethyl)amino-phenyl, their preparation, their use as medicaments and the pharmaceutical compositions containing them (2008-12-02),

14. 7384933 - Derivatives of 2-hydroxytetrahydrofuran and their use as medicaments (2008-06-10),

15. 7244711 - Association of calpain inhibitors and reactive oxygen species trapping agents (2007-07-17),

Title: Innovations by Serge Auvin in Pharmaceutical Sciences

Introduction

Serge Auvin, based in Palaiseau, France, is a distinguished inventor with an impressive portfolio of 35 patents. His contributions to the field of pharmaceutical sciences focus on innovative compounds that address critical health challenges, including cancer and hormone-dependent diseases.

Latest Patents

Among his latest patents, Auvin has developed “Imidazolidine-2,4-dione derivatives,” which are compounds exhibiting anti-proliferative activity. These derivatives are particularly useful in treating conditions associated with abnormal cell proliferation, such as cancer. Another significant innovation is his work on “Substituted biphenyl analogues as dual inhibitors of aromatase and sulfatase.” These biphenyl derivatives serve as inhibitors for both enzymes and play a vital role in the treatment of conditions linked to hormone-dependent cancers, providing a new avenue for therapeutic interventions.

Career Highlights

Throughout his career, Auvin has been associated with prominent organizations such as Société de Conseils de Recherches et d'Applications Scientifiques (S.C.R.A.S.) and Ipsen Pharma S.A.S. His experience in these respected companies has enabled him to advance his research and patent significant innovations within the pharmaceutical industry.

Collaborations

Serge Auvin has collaborated with notable colleagues, including Dennis Bigg and Pierre-Etienne Chabrier de Lassauniere. These collaborations have contributed to his research endeavors, facilitating the development of novel pharmaceutical compounds and the filing of patents that address pressing medical needs.

Conclusion

Serge Auvin stands out as a prolific inventor whose work continues to pave the way for advancements in the treatment of critical diseases. His 35 patents reflect a deep commitment to innovation in pharmaceutical sciences, marking him as a key figure in this vital industry.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to [email protected]